Deferasirox
Exjade, Jadenu, Jadenu Sprinkle (deferasirox) is a small molecule pharmaceutical. Deferasirox was first approved as Exjade on 2005-11-02. It is used to treat iron overload in the USA. It has been approved in Europe to treat beta-thalassemia and iron overload. Exjade's patent is valid until 2034-11-21 (FDA).
| Trade Name | Exjade |
|---|---|
| Common Name | Deferasirox |
| Indication | beta-thalassemia, iron overload |
| Drug Class |
